Targeted Drug ROS1 Inhibitors for NSCLC Market- China, Japan, South Korea,Indonesia, Malaysia, UAE, Hong Kong, Singapore, Qatar, Egypt
Targeted Drug ROS1 Inhibitors for NSCLC Market size was valued at USD 1.2 Billion in 2024 and is forecasted to grow at a CAGR of 12.5% from 2026 to 2033, reaching USD 3.5 Billion by 2033. Targeted Drug ROS1 Inhibitors for NSCLC Market : Key Highlights * Strategic focus